Followers | 3203 |
Posts | 159336 |
Boards Moderated | 3 |
Alias Born | 06/03/2011 |

Friday, May 02, 2025 2:28:10 PM
Yeah..scammers LMAO
💎 $TWOH I’M #LONG WITH EMIL & CRAIG !! ✅All The Way Up To NASDAQ !! #StrongBuy #Nasdaq #UpList #SPAC #OTC #MergersandAcquistiobs #Trump #AI #StockToBuy #Invest #Stocks #Longs
🔥Did you know Craig Marshak $TWOH BOD provided the first round institutional funding for DealTime/Shopping.com which was later sold to $EBAY for over $600Million Dollars
Emil Assentato
President, CEO, Secretary, Treasurer & Director, Two Hands Corp.
Emil Assentato was the founder of FXDirectDealer LLC, founded in 2006, holding the title of Chairman. Mr. Assentato is currently the Chairman & Chief Executive Officer of Tradition Securities & Derivatives, Inc. since 2012, the Chairman & Chief Executive Officer of Triton Capital Markets Ltd. since 2010, the Chairman & Chief Executive Officer of Currency Mountain Holdings LLC since 2010, the Chairman & Chief Executive Officer of Currency Mountain Holdings Bermuda Ltd. since 2003, the President, CEO, Secretary, Treasurer & Director of Two Hands Corp. starting in 2025, the Chairman of Tradition America LLC, the Chairman of Standard Credit Group LLC since 2008, the Director of Streamingedge, Inc. since 2014, the Director of Tradermade Systems Ltd. since 2015, and a Member of Max Q Investments LLC. Former positions include Chairman, President, Chief Executive Officer & CFO of Nukkleus, Inc. in 2024, Chairman, President, CEO, Secretary & Treasurer of Nukkleus, Inc. (New Jersey), and Director of CSA Holdings, Inc. Education includes an undergraduate degree from Hofstra University, conferred in 1971.
Craig Marshak
Director, Two Hands Corp.
Craig Marshak is the founder of Moringa Acquisition Corp. since 2021, holding the title of Vice Chairman. Current jobs include Co-Chairman at Bannix Acquisition Corp. since 2022, Director at Two Hands Corp. since 2025, and Principal at Triple Eight Markets, Inc. Former jobs include Chairman at Fragrant Prosperity Holdings Ltd., Managing Director & Co-Head at Nomura Holdings, Inc., Independent Director at HUTN, Inc., Director at Nukkleus, Inc. (New Jersey) from 2016 to 2023, Director-Investment Banking at Schroder Wertheim & Co., Inc. from 1985 to 1995, Managing Director & Partner at Israel Venture Partners Ltd. from 2010 to 2014, Managing Director at Ledgemont Private Equity, Independent Director at Changda International Holdings, Inc. in 2012, Director & Head-International Investment Banking at Arbel Capital Ltd., Managing Director at Cross Point Capital Advisors LLC from 2010 to 2014, Director at Nukkleus, Inc., Managing Director & Global Co-Head at Nomura Technology Investment Growth Fund, Principal at Morgan Stanley, Principal at Nomura Securities International, Inc., Principal at Robertson Stephens & Co., and Partner & Head-Investment Banking at Trafalgar Capital Advisors from 2007 to 2010. Education includes an undergraduate degree from Duke University conferred in 1981 and a graduate degree from Harvard Law School.

Recent TWOH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 09:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 04:14:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:43:22 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2025 08:58:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 07:32:06 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2025 12:35:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/14/2025 06:44:17 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/14/2025 06:43:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/28/2025 11:12:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/24/2025 01:19:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 04:13:35 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 01/10/2025 04:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2024 09:12:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/18/2024 10:18:48 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2024 09:03:41 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM